TP53 and neoplasm: The inhibition of autophagy sensitised colon cancer cells with wild-type p53 to topotecan treatment; however, autophagy inhibition attenuated the anti-tumour effect of topotecan treatment in p53 mutant or knockout colon cancer cells both in vitro and in vivo.